The same trend was observed in hyperuricemic patients treated with febuxostat; however, it did not reach statistical significance.
← all excerpts
Hyperuricemia-Especially "Metabolic Hyperuricemia"-Is Independently Associated with a Higher Risk of Steatotic Liver Disease.
1
—
—